If the pH value of the peptide is too high or too low, turbidity, gelation, burning, and tingling will occur. Generally speaking, these can be adjusted by buffer solvents. For most peptides, using buffer solvents to adjust the pH value is stable. Special peptides should consider optimization strategies in the form of salts or modifications.
1. The effect of pH on drugs
The effect of pH on drugs is mainly reflected in drug absorption, drug ratio, and drug excretion.
1. Drug absorption: The effect of pH on drug absorption is mainly reflected in gastrointestinal absorption and renal reabsorption.
In terms of gastrointestinal absorption, some drugs may cause changes in the pH value in the gastrointestinal tract, thereby affecting the absorption and utilization of drugs. In terms of renal reabsorption, different pH values of urine will affect the excretion and reabsorption of drugs.
2. Drug compatibility: pH also has an important influence on drug compatibility. Some drugs are unstable at specific pH values and are prone to decomposition or chemical reactions.
3. Drug excretion: pH also affects the excretion process of drugs. For example, alkalinizing urine can promote the renal metabolism of certain acidic drugs, thereby improving the therapeutic effect of diseases such as urinary tract infections.
2. The effect of pH on polypeptides
The effect of pH on polypeptides is mainly reflected in the effect of environmental conditions on polypeptide folding and stability.
The structural stability of polypeptides is mainly determined by two aspects: one is the sequence and secondary structure of the peptide chain itself, and the other is the physical and chemical conditions of the background environment.
Changes in pH can directly affect the spatial configuration and function of polypeptides, and thus affect their stability. In an alkaline environment, some polypeptides may form complexes with other substances, and this structure may change the structure of polypeptides, thereby affecting the activity of polypeptide drugs.
The secondary structure is a specific conformation formed by the backbone atoms of the polypeptide main chain circling or folding along a certain axis, that is, the spatial position arrangement of the backbone atoms of the polypeptide chain, without involving the side chains of amino acid residues.
If the pH value is not controlled within a reasonable range, some peptide protective groups may fall off, the secondary structure may be destroyed, and its activity may be reduced or completely inactivated. Each peptide needs to determine that its pH value is optimal when adjusted to neutral conditions. The range of neutral conditions can refer to the following data:
· The pH value of pure water is: 6.5-8.5.
· The pH value of physiological saline is: 7-7.5.
Reaching this range can effectively avoid many influences during the experiment.
It is worth noting that for some specific peptides, the pH value may cause precipitation under neutral conditions, making it impossible to dissolve in sterile water, which is another matter.
Solution
1. When synthesizing peptides, it is determined to change the optimization strategy in salt form to solve the problems of gelation, turbidity, burning, stinging, etc. caused by pH value, so as to presuppose that the peptides currently under development will eventually reach a reasonable pH range. This is effective, but not suitable for all products, but it is a very good idea.
2. Through buffer solvent adjustment, when the experimental reagent is acidic, sodium citrate can be considered; baking soda, when it is alkaline, citric acid can be used.
Bingyan Gao
ໂປຣໄຟລ໌: Bingyan Gao ແມ່ນ "ຜູ້ຮັກສາປະຕູສູງສຸດ" ຂອງຄວາມບໍລິສຸດແລະຄຸນນະພາບ peptide. ລາວມີຄວາມຊໍານິຊໍານານໃນການນໍາໃຊ້ເຄື່ອງມືການວິເຄາະລະດັບສູງຕ່າງໆແລະມີຄວາມຊ່ຽວຊານໃນການພັດທະນາວິທີການແຍກ chromatographic ທີ່ກໍາຫນົດເອງສໍາລັບ peptides ທີ່ມີການແກ້ໄຂສະລັບສັບຊ້ອນສູງ.. ລາວໄດ້ສ້າງຕັ້ງລະບົບ profileing impurity ຢ່າງເຂັ້ມງວດທີ່ບໍ່ພຽງແຕ່ຮັບປະກັນຄວາມບໍລິສຸດຂອງຜະລິດຕະພັນ 99% ຫຼືສູງກວ່າແຕ່ຍັງກໍານົດຢ່າງຊັດເຈນແລະກໍາຈັດສິ່ງເສດເຫຼືອຕາມຮອຍທີ່ອາດຈະເຮັດໃຫ້ເກີດພູມຕ້ານທານ.. ດ້ວຍຄວາມເຂົ້າໃຈຢ່າງເລິກເຊິ່ງກ່ຽວກັບຂໍ້ກໍານົດກົດລະບຽບຂອງ FDA ແລະ EMA ສໍາລັບຢາ peptide, ລາວຮັບປະກັນວ່າທຸກໆຊຸດທີ່ປ່ອຍອອກມາຈາກສະຖານທີ່ແມ່ນມາພ້ອມກັບໃບຢັ້ງຢືນການວິເຄາະທີ່ສົມບູນແບບແລະມີອໍານາດ. (COA).
- Expanded Genetic Codes for Custom Peptide Design 2026年9月25日
- Modified Peptide Characterization: Why One Atom Matters 2026年9月25日
- BPC-157 Characterization: Why "99% Pure" Isn't Enough 2026年9月25日
- Cyclic Peptide PROTAC Design: HIF-1α Degradation Guide 2026年9月25日
- Peptide Supplier Scale vs Specialization: 2026 Buyer Guide 2026年9月24日
ຂະບວນການກວດສອບຄວາມຈິງຂອງພວກເຮົາ
ພວກເຮົາຈັດລໍາດັບຄວາມສໍາຄັນຂອງຄວາມຖືກຕ້ອງແລະຄວາມຊື່ສັດໃນເນື້ອຫາຂອງພວກເຮົາ. ນີ້ແມ່ນວິທີທີ່ພວກເຮົາຮັກສາມາດຕະຖານສູງ:
- ການທົບທວນຄືນຂອງຜູ້ຊ່ຽວຊານ: ບົດຄວາມທັງຫມົດແມ່ນທົບທວນໂດຍຜູ້ຊ່ຽວຊານດ້ານວິຊາ.
- ການກວດສອບແຫຼ່ງທີ່ມາ: ຂໍ້ມູນແມ່ນສະຫນັບສະຫນູນໂດຍທີ່ເຊື່ອຖືໄດ້, ແຫຼ່ງຂໍ້ມູນທີ່ທັນສະ ໄໝ.
- ຄວາມໂປ່ງໃສ: ພວກເຮົາອ້າງເຖິງການອ້າງອີງຢ່າງຊັດເຈນ ແລະເປີດເຜີຍຂໍ້ຂັດແຍ່ງທີ່ອາດຈະເກີດຂຶ້ນ.
ຄະນະກວດກາຂອງພວກເຮົາ
ເນື້ອຫາຂອງພວກເຮົາຖືກກວດສອບຢ່າງລະມັດລະວັງໂດຍຜູ້ຊ່ຽວຊານທີ່ມີປະສົບການເພື່ອຮັບປະກັນຄວາມຖືກຕ້ອງແລະຄວາມກ່ຽວຂ້ອງ.
- ຜູ້ຊ່ຽວຊານທີ່ມີຄຸນວຸດທິ: ແຕ່ລະບົດຄວາມຖືກປະເມີນໂດຍຜູ້ຊ່ຽວຊານດ້ານຄວາມຮູ້ສະເພາະ.
- ຂໍ້ມູນເຈາະເລິກທັນສະໄຫມ: ພວກເຮົາລວມເອົາການຄົ້ນຄວ້າຫລ້າສຸດ, ແນວໂນ້ມ, ແລະມາດຕະຖານ.
- ຄໍາຫມັ້ນສັນຍາກັບຄຸນນະພາບ: ຜູ້ທົບທວນຮັບປະກັນຄວາມຊັດເຈນ, ຄວາມຖືກຕ້ອງ, ແລະຄວາມສົມບູນ.
ຊອກຫາປ້າຍທີ່ຜູ້ຊ່ຽວຊານທົບທວນຄືນເພື່ອອ່ານເນື້ອຫາທີ່ທ່ານສາມາດໄວ້ວາງໃຈໄດ້.
